Nasen (Zolpidem Tartrate)

Zolpidem tartrate acts as a positive allosteric modulator at the benzodiazepine site of the GABA_A receptor complex. By enhancing GABA‑mediated chloride influx, it reduces neuronal excitability, producing a sedative‑hypnotic effect that facilitates the initiation and maintenance of sleep.

The appropriate dose of Nasen is determined by the prescribing clinician based on the patient’s age, health status, and response to therapy. Dosage instructions are provided on the prescription label and should be followed exactly as directed by the healthcare professional.

Safety of zolpidem tartrate in pregnancy or while breastfeeding has not been definitively established. Healthcare providers usually weigh potential benefits against possible risks and may recommend alternative treatments if safer options are available.

To order Nasen, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nasen (zolpidem tartrate) is a short‑acting hypnotic that typically produces rapid sleep onset with a lower risk of next‑day sedation compared with longer‑acting benzodiazepines. It is often preferred for brief, acute insomnia episodes, whereas other agents may be chosen for chronic insomnia or specific comorbid conditions.

Store Nasen at room temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Nasen is taken orally, usually as a single dose right before bedtime. It should be swallowed whole with a glass of water and taken only when the patient can dedicate a full night (7–8 hours) to sleep.

Serious risks include complex sleep behaviors such as sleepwalking, driving, or eating while not fully awake, as well as rare allergic reactions that may cause rash, swelling, or breathing difficulties. Patients should seek immediate medical attention if these events occur.

Nasen should be avoided in individuals with known hypersensitivity to zolpidem or any component of the formulation, those with severe hepatic impairment, and patients with a history of complex sleep behaviors or substance dependence unless specifically directed by a physician.